[{"address1": "42127 Pleasant Forest Court", "city": "Ashburn", "state": "VA", "zip": "20148-7349", "country": "United States", "phone": "703 980 4182", "website": "https://quoinpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Quoin Pharmaceuticals, Ltd., a late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). It also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat Netherton Syndrome; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Dr. Michael  Myers Ph.D.", "age": 62, "title": "Co-Founder, CEO & Chairman", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 722550, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Denise  Carter", "age": 55, "title": "Co-Founder, COO & Director", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 593605, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gordon Bruce Dunn J.D.", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 433620, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.755, "open": 8.95, "dayLow": 8.75, "dayHigh": 8.95, "regularMarketPreviousClose": 8.755, "regularMarketOpen": 8.95, "regularMarketDayLow": 8.75, "regularMarketDayHigh": 8.95, "payoutRatio": 0.0, "beta": 1.784, "forwardPE": -7.2892556, "volume": 7853, "regularMarketVolume": 7853, "averageVolume": 286895, "averageVolume10days": 21460, "averageDailyVolume10Day": 21460, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 5187633, "fiftyTwoWeekLow": 5.01, "fiftyTwoWeekHigh": 54.95, "fiftyDayAverage": 7.40662, "twoHundredDayAverage": 16.16368, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 172788160, "profitMargins": 0.0, "floatShares": 18047816, "sharesOutstanding": 588167, "sharesShort": 225364, "sharesShortPriorMonth": 12505, "sharesShortPreviousMonthDate": 1744675200, "dateShortInterest": 1747267200, "sharesPercentSharesOut": 0.3832, "heldPercentInsiders": 0.07077, "heldPercentInstitutions": 0.07203, "shortRatio": 0.47, "shortPercentOfFloat": 1.7061, "impliedSharesOutstanding": 20585800, "bookValue": 10.075, "priceToBook": 0.8754342, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -10447371, "trailingEps": -34.62, "forwardEps": -1.21, "lastSplitFactor": "1:35", "lastSplitDate": 1744156800, "enterpriseToEbitda": -15.812, "52WeekChange": -0.6594595, "SandP52WeekChange": 0.119305134, "quoteType": "EQUITY", "currentPrice": 8.82, "targetHighPrice": 350.00034, "targetLowPrice": 30.0, "targetMeanPrice": 150.00014, "targetMedianPrice": 70.00007, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 11552720, "totalCashPerShare": 0.561, "ebitda": -10927358, "totalDebt": 2773733, "quickRatio": 2.379, "currentRatio": 2.574, "debtToEquity": 46.808, "returnOnAssets": -0.47404, "returnOnEquity": -1.38823, "freeCashflow": -5324791, "operatingCashflow": -9017116, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "QNRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1749254369, "regularMarketTime": 1749240000, "exchange": "NCM", "messageBoardId": "finmb_593010770", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.7424281, "regularMarketPrice": 8.82, "dividendDate": 1571788800, "earningsTimestamp": 1747137603, "earningsTimestampStart": 1754483400, "earningsTimestampEnd": 1754915400, "earningsCallTimestampStart": 1710419400, "earningsCallTimestampEnd": 1710419400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -34.62, "epsForward": -1.21, "epsCurrentYear": -17.50002, "priceEpsCurrentYear": -0.5039994, "fiftyDayAverageChange": 1.4133797, "fiftyDayAverageChangePercent": 0.19082654, "twoHundredDayAverageChange": -7.3436794, "twoHundredDayAverageChangePercent": -0.45433217, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "shortName": "Quoin Pharmaceuticals, Ltd.", "longName": "Quoin Pharmaceuticals, Ltd.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1470058200000, "postMarketChangePercent": -2.6077, "postMarketPrice": 8.59, "postMarketChange": -0.23, "regularMarketChange": 0.06499958, "regularMarketDayRange": "8.75 - 8.95", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 286895, "fiftyTwoWeekLowChange": 3.8099995, "fiftyTwoWeekLowChangePercent": 0.7604789, "fiftyTwoWeekRange": "5.01 - 54.95", "fiftyTwoWeekHighChange": -46.13, "fiftyTwoWeekHighChangePercent": -0.8394905, "fiftyTwoWeekChangePercent": -65.945946, "marketState": "CLOSED", "displayName": "Quoin Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-06-07"}]